Monitoring the effect of antiviral treatment on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients
Kamil Mert, Bengu Tatar, Yasemin Nadir, Suheyla Serin Senger · 2024
Read Monitoring the effect of antiviral treatment on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients by Kamil Mert, Bengu Tatar, Yasemin Nadir, Suheyla Serin Senger (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11639565.txt.
Description
Kamil Mert and co-authors tracked liver risk in hepatitis B patients on long antiviral care, in a 2024 study. The drugs hold back the virus and cut the odds of scarring and liver cancer, yet the risk never falls to zero. The team followed 218 patients over ten years, watching two blood-based scarring scores at years one, five, and ten.
They also set each patient's forecast cancer risk, had no treatment started, beside the cancers that in fact appeared. Scarring scores fell notably over the decade of care. The study weighs how well such scores and risk tools track real danger during long treatment, to guide how closely patients are watched.
Catalog record
| CREATOR | Kamil Mert, Bengu Tatar, Yasemin Nadir, Suheyla Serin Senger |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |